Cargando…

A simulation study on the impact of the blood flow-dependent component in [(18)F]AV45 SUVR in Alzheimer’s disease

BACKGROUND: Increased brain uptake on [(18)F]AV45 PET is a biomarker for Alzheimer’s disease (AD). The standardised uptake value ratio (SUVR) is widely used for quantification but is subject to variability. Here we evaluate how SUVR of a cortical target region is affected by blood flow changes in th...

Descripción completa

Detalles Bibliográficos
Autores principales: Ottoy, Julie, Verhaeghe, Jeroen, Niemantsverdriet, Ellis, Engelborghs, Sebastiaan, Stroobants, Sigrid, Staelens, Steven
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5718604/
https://www.ncbi.nlm.nih.gov/pubmed/29211812
http://dx.doi.org/10.1371/journal.pone.0189155
_version_ 1783284348744630272
author Ottoy, Julie
Verhaeghe, Jeroen
Niemantsverdriet, Ellis
Engelborghs, Sebastiaan
Stroobants, Sigrid
Staelens, Steven
author_facet Ottoy, Julie
Verhaeghe, Jeroen
Niemantsverdriet, Ellis
Engelborghs, Sebastiaan
Stroobants, Sigrid
Staelens, Steven
author_sort Ottoy, Julie
collection PubMed
description BACKGROUND: Increased brain uptake on [(18)F]AV45 PET is a biomarker for Alzheimer’s disease (AD). The standardised uptake value ratio (SUVR) is widely used for quantification but is subject to variability. Here we evaluate how SUVR of a cortical target region is affected by blood flow changes in the target and two frequently used reference regions. METHODS: Regional baseline time-activity curves (TACs) were simulated based on metabolite-corrected plasma input functions and pharmacokinetic parameters obtained from our previously acquired data in healthy control (HC; n = 10), amnestic mild cognitive impairment (aMCI; n = 15) and AD cohorts (n = 9). Blood flow changes were simulated by altering the regional tracer delivery rate K1 (and clearance rate k2) between -40% and +40% from its regional baseline value in the target region and/or cerebellar grey (CB) or subcortical white matter (WM) reference regions. The corresponding change in SUVR was calculated at 50–60 min post-injection. RESULTS: A -40% blood flow reduction in the target resulted in an increased SUVR(target) (e.g. SUVR(precuneus): +10.0±5% in HC, +2.5±2% in AD), irrespective of the used reference region. A -40% blood flow reduction in the WM reference region increased SUVR(WM) (+11.5±4% in HC, +13.5±3% in AD) while a blood flow reduction in CB decreased SUVR(CB) (-9.5±6% in HC, -5.5±2% in AD), irrespective of the used target region. A -40% flow reduction in both the precuneus and reference WM (i.e., global flow change) induced an increased SUVR (+22.5±8% in HC, +16.0±4% in AD). When considering reference CB instead, SUVR was decreased by less than -5% (both in HC and AD). CONCLUSION: Blood flow changes introduce alterations in [(18)F]AV45 PET SUVR. Flow reductions in the CB and WM reference regions resulted in a decreased and increased SUVR of the target, respectively. SUVR was more affected by global blood flow changes when considering WM instead of CB normalization.
format Online
Article
Text
id pubmed-5718604
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-57186042017-12-15 A simulation study on the impact of the blood flow-dependent component in [(18)F]AV45 SUVR in Alzheimer’s disease Ottoy, Julie Verhaeghe, Jeroen Niemantsverdriet, Ellis Engelborghs, Sebastiaan Stroobants, Sigrid Staelens, Steven PLoS One Research Article BACKGROUND: Increased brain uptake on [(18)F]AV45 PET is a biomarker for Alzheimer’s disease (AD). The standardised uptake value ratio (SUVR) is widely used for quantification but is subject to variability. Here we evaluate how SUVR of a cortical target region is affected by blood flow changes in the target and two frequently used reference regions. METHODS: Regional baseline time-activity curves (TACs) were simulated based on metabolite-corrected plasma input functions and pharmacokinetic parameters obtained from our previously acquired data in healthy control (HC; n = 10), amnestic mild cognitive impairment (aMCI; n = 15) and AD cohorts (n = 9). Blood flow changes were simulated by altering the regional tracer delivery rate K1 (and clearance rate k2) between -40% and +40% from its regional baseline value in the target region and/or cerebellar grey (CB) or subcortical white matter (WM) reference regions. The corresponding change in SUVR was calculated at 50–60 min post-injection. RESULTS: A -40% blood flow reduction in the target resulted in an increased SUVR(target) (e.g. SUVR(precuneus): +10.0±5% in HC, +2.5±2% in AD), irrespective of the used reference region. A -40% blood flow reduction in the WM reference region increased SUVR(WM) (+11.5±4% in HC, +13.5±3% in AD) while a blood flow reduction in CB decreased SUVR(CB) (-9.5±6% in HC, -5.5±2% in AD), irrespective of the used target region. A -40% flow reduction in both the precuneus and reference WM (i.e., global flow change) induced an increased SUVR (+22.5±8% in HC, +16.0±4% in AD). When considering reference CB instead, SUVR was decreased by less than -5% (both in HC and AD). CONCLUSION: Blood flow changes introduce alterations in [(18)F]AV45 PET SUVR. Flow reductions in the CB and WM reference regions resulted in a decreased and increased SUVR of the target, respectively. SUVR was more affected by global blood flow changes when considering WM instead of CB normalization. Public Library of Science 2017-12-06 /pmc/articles/PMC5718604/ /pubmed/29211812 http://dx.doi.org/10.1371/journal.pone.0189155 Text en © 2017 Ottoy et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Ottoy, Julie
Verhaeghe, Jeroen
Niemantsverdriet, Ellis
Engelborghs, Sebastiaan
Stroobants, Sigrid
Staelens, Steven
A simulation study on the impact of the blood flow-dependent component in [(18)F]AV45 SUVR in Alzheimer’s disease
title A simulation study on the impact of the blood flow-dependent component in [(18)F]AV45 SUVR in Alzheimer’s disease
title_full A simulation study on the impact of the blood flow-dependent component in [(18)F]AV45 SUVR in Alzheimer’s disease
title_fullStr A simulation study on the impact of the blood flow-dependent component in [(18)F]AV45 SUVR in Alzheimer’s disease
title_full_unstemmed A simulation study on the impact of the blood flow-dependent component in [(18)F]AV45 SUVR in Alzheimer’s disease
title_short A simulation study on the impact of the blood flow-dependent component in [(18)F]AV45 SUVR in Alzheimer’s disease
title_sort simulation study on the impact of the blood flow-dependent component in [(18)f]av45 suvr in alzheimer’s disease
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5718604/
https://www.ncbi.nlm.nih.gov/pubmed/29211812
http://dx.doi.org/10.1371/journal.pone.0189155
work_keys_str_mv AT ottoyjulie asimulationstudyontheimpactofthebloodflowdependentcomponentin18fav45suvrinalzheimersdisease
AT verhaeghejeroen asimulationstudyontheimpactofthebloodflowdependentcomponentin18fav45suvrinalzheimersdisease
AT niemantsverdrietellis asimulationstudyontheimpactofthebloodflowdependentcomponentin18fav45suvrinalzheimersdisease
AT engelborghssebastiaan asimulationstudyontheimpactofthebloodflowdependentcomponentin18fav45suvrinalzheimersdisease
AT stroobantssigrid asimulationstudyontheimpactofthebloodflowdependentcomponentin18fav45suvrinalzheimersdisease
AT staelenssteven asimulationstudyontheimpactofthebloodflowdependentcomponentin18fav45suvrinalzheimersdisease
AT ottoyjulie simulationstudyontheimpactofthebloodflowdependentcomponentin18fav45suvrinalzheimersdisease
AT verhaeghejeroen simulationstudyontheimpactofthebloodflowdependentcomponentin18fav45suvrinalzheimersdisease
AT niemantsverdrietellis simulationstudyontheimpactofthebloodflowdependentcomponentin18fav45suvrinalzheimersdisease
AT engelborghssebastiaan simulationstudyontheimpactofthebloodflowdependentcomponentin18fav45suvrinalzheimersdisease
AT stroobantssigrid simulationstudyontheimpactofthebloodflowdependentcomponentin18fav45suvrinalzheimersdisease
AT staelenssteven simulationstudyontheimpactofthebloodflowdependentcomponentin18fav45suvrinalzheimersdisease